thiopyranothiazol
scaffold
character
fix
biophor
rigid
condens
system
allow
save
biolog
activ
synthet
precursor
relat
heterocycl
compris
suffici
studi
class
compound
reveal
wide
spectrum
biolog
activ
antiinflammatori
antimicrobi
antifung
antivir
anticanc
anticonvuls
antitubercul
etc
among
thiazolidinon
deriv
number
drug
candid
well
approv
drug
exampl
antihyperglycem
glitazon
agonist
pioglitazon
deriv
aldos
reductas
rhodanin
deriv
antiinflammatori
deriv
diuret
ethozolin
deriv
anticonvuls
ralitolin
howev
recent
rich
pharmacolog
profil
thiazolidinon
consid
medicin
chemist
advantag
drawback
exampl
activ
subgroup
classifi
pain
pan
assay
interfer
compound
defin
abil
show
activ
across
rang
assay
toward
rang
protein
argu
varieti
inher
biolog
activ
low
select
abil
michael
acceptor
despit
rigor
select
base
sar
analysi
prove
select
leav
compound
right
life
medicin
chemistri
moreov
object
review
thiopyranothiazol
consid
biomimet
pharmacolog
activ
without
mention
michael
acceptor
properti
figur
combin
thiazol
thiopyran
cycl
condens
heterosystem
precondit
creation
center
conserv
ligandtarget
bind
complex
promot
potenti
select
biotarget
consid
mention
argument
direct
search
new
chemotherapeut
agent
among
thiopyrano
thiazol
deriv
justifi
promis
direct
modern
medicin
chemistri
review
tri
systemat
data
chemistri
pharmacolog
thiopyrano
thiazol
perspect
medicin
pharmaceut
chemistri
thiorhodanin
prepar
knoevenagel
reaction
correspond
turn
synthes
thionat
reaction
rhodanin
scheme
thionat
reaction
commonli
carri
anhydr
dioxan
lawesson
reagent
lr
green
method
synthesi
peg
medium
room
temperatur
without
ad
catalyst
recent
report
import
note
thionat
lawesson
reagent
xylen
medium
result
format
thion
dimer
due
spontan
cycloaddit
reaction
intermedi
scheme
mention
synthesi
lead
format
thiorhodanin
spirosubstitut
thiopyrano
thiazol
high
yield
absenc
byproduct
pioneer
work
chemistri
thiopyrano
thiazol
dienophil
compon
repres
maleic
acid
deriv
maleic
anhydrid
maleinimid
acryl
acid
deriv
methyl
acryl
ethyl
acryl
acrylonitril
therefor
allow
obtain
compound
scheme
current
list
dienophil
synthesi
thiopyrano
thiazol
deriv
significantli
expand
thu
use
cynnam
acid
amid
aroylacryl
aryliden
pyruv
acid
well
dimethyl
acetylenedicarboxyl
propiol
acid
ethyl
ester
acrolein
acid
imid
dienophil
allow
obtain
new
thiopyrano
thiazol
promis
biolog
activ
compound
base
thiazolidinon
matrix
scheme
note
presenc
chiral
center
structur
thiopyrano
thiazol
cycl
caus
certain
featur
stereochemistri
reaction
given
issu
becam
subject
intens
studi
consid
current
trend
organ
medicin
chemistri
found
abovement
cycloaddit
regio
diastereoselect
reaction
furanon
yield
mixtur
endoexo
adduct
scheme
consid
moder
diastereoselect
process
reaction
occur
endo
exo
transit
state
result
differ
posit
proton
core
heterocycl
thu
endo
transit
state
lead
anti
configur
exo
geometri
result
syn
configur
respect
endo
exo
adduct
separ
column
chromatographi
reaction
transaconit
acid
proce
regio
diastereoselect
cycloaddit
spontan
decarboxyl
adduct
furnish
rel
diastereom
product
synthes
use
itacon
acid
dienophil
interestingli
onepot
threecompon
reaction
transaconit
acid
anilin
diastereoselect
yield
rel
spiro
thiazol
without
decarboxyl
adduct
thiopyrano
thiazol
contrari
synthes
use
acet
acid
dienophil
note
unlik
free
transaconit
acid
imid
correspond
trimethyl
ester
trimethyl
react
opposit
regioselect
result
cycloadduct
scheme
case
util
dienophil
intermedi
cycloaddit
reaction
undergo
spontan
oxid
format
tetracycl
thiopyrano
thiazol
scheme
compound
dicyclopentadien
norbornadien
react
similar
manner
norbornen
deriv
scheme
compound
case
norbornadien
symmetr
bisadduct
regioselect
form
structur
deriv
predict
scheme
diversif
thiopyranothiazol
bear
norbornan
moieti
hydrazin
use
obtain
fuse
thiopyrano
thiazol
via
two
altern
method
scheme
one
way
involv
obtain
compound
heterodielsald
reaction
bicyclo
anhydrid
endic
anhydrid
follow
condens
triazinelhydrazin
toluen
medium
presenc
thionyl
chlorid
whilst
way
includ
condens
triazin
endic
anhydrid
dmf
medium
firstli
reaction
yield
correspond
cycloaddit
product
scheme
turn
effect
dienophyl
reaction
allow
obtain
thiopyrano
thiazol
nh
metwal
colleagu
chosen
terephthal
aldehyd
thio
isorhodanin
start
reagent
order
investig
peculiar
reaction
basi
start
reagent
monoaryliden
thiorhodanin
bicycl
aryliden
isorhodanin
deriv
prepar
knoevenagel
condens
use
heterodien
phenyl
maleinimid
ethyl
acryl
use
dienophil
enabl
synthes
compound
scheme
use
import
reagent
search
biolog
activ
compound
allow
obtain
thiopyrano
thiazol
deriv
rel
low
molecular
weight
among
correspond
thiorhodanin
interest
effect
heterodien
significantli
expand
structur
divers
thiopyrano
thiazol
scheme
earli
work
dedic
issu
number
specif
featur
mention
reaction
experiment
establish
outlin
particular
cycloaddit
thiorhodanin
appropri
dienophil
toluen
medium
room
temperatur
pass
classic
reaction
format
thiazol
chang
reaction
medium
acet
acid
heat
reaction
mixtur
elimin
ethanol
molecul
format
addit
doubl
bond
correspond
thiazol
observ
analog
pattern
observ
cycloaddit
acrolein
croton
aldehyd
acid
imid
medium
acet
acid
allow
obtain
heterocycl
aldehyd
polycycl
heterosystem
interact
propiol
acid
accompani
elimin
ethanol
rearrang
doubl
bond
format
acid
compound
also
form
use
acetylen
dicarboxyl
acid
dienophil
may
explain
similar
transform
cycloadduct
addit
decarboxyl
posit
adduct
aroylacryl
acid
also
undergo
elimin
ethanol
decarboxyl
regioselect
format
time
interact
accompani
spontan
intermedi
dehydrogen
format
addit
endocycl
doubl
bond
elimin
ethanol
molecul
yield
thiochromeno
scheme
one
rel
new
area
thiopyrano
thiazol
chemistri
usag
cyclo
alkylideneisorhodanin
key
reagent
cycloaddit
scheme
thu
initi
heterodien
obtain
reaction
isorhodanin
aceton
cyclopentanon
cyclohexanon
room
temperatur
presenc
triethylamin
catalyst
interestingli
perform
reaction
ethanol
medium
solvent
boil
point
lead
format
tricycl
heterosystem
thiorhodanin
use
condens
deriv
form
regardless
reaction
condit
cycloaddit
cyclo
alkylideneisorhodanin
arylmaleinamid
acet
acid
yield
low
molecular
thiopyrano
thiazol
michael
reaction
one
effect
approach
synthesi
thiopyrano
thiazol
scheme
thu
interact
arylmethylen
malononitril
isorhodanin
medium
absolut
ethanol
presenc
triethylamin
gave
fm
abdelrazek
coauthor
use
approach
synthesi
pyrano
thiazol
thioanalog
scheme
reaction
isorhodanin
methylenemalononitril
yield
thiopyrano
xs
use
pyrano
thiazol
xo
form
interestingli
acrylonitril
michael
reaction
isorhodanin
elimin
water
hydrogen
sulphid
respect
form
studi
peculiar
michael
addit
bicycl
thio
rhodanin
malonodinitril
bisthiopyrano
thiazol
deriv
obtain
earli
synthes
reaction
benzen
two
equival
isorhodanin
second
case
format
deriv
occur
twostag
process
includ
initi
michael
reaction
cycliz
intermedi
attack
cyano
group
mercapto
group
thiazol
cycl
scheme
unexpected
zhang
coauthor
obtain
thiopyranoid
scaffold
scheme
explor
diverg
organocatalit
michaelmichaelaldol
cascad
reaction
isorhodanin
aldehyd
whilst
condit
reaction
thiazolidinedion
rhodanin
enal
led
spiro
compound
case
isorhodanin
usag
michael
cycliz
took
place
optim
reaction
condit
author
use
toluen
medium
organ
catalyst
room
temperatur
presenc
activ
group
oposit
aryliden
fragment
import
featur
contribut
pass
tandem
process
base
michael
reaction
synthesi
thiopyrano
thiazol
exampl
id
komaritsa
na
kassab
use
isorhodanin
reaction
acryl
acid
ethyl
ester
amid
obtain
thiopyrano
high
yield
mention
reaction
twostep
process
involv
combin
hetero
dien
synthesi
acyl
phenol
group
first
exampl
tandem
reaction
scheme
base
experiment
conclus
id
komaritsa
na
kassab
metwal
coauthor
perform
similar
tandem
process
synthes
polycycl
system
reaction
iso
thio
rhodanin
ethyl
acryl
acrylonitril
moreov
michael
reaction
malononitril
led
structur
similar
thiopyrano
scheme
among
tandem
reaction
two
type
process
distinguish
acyl
hemiacetalbas
reaction
scheme
first
approach
requir
usag
deriv
carboxyl
acid
dienophil
oxo
compound
aldehyd
keton
thu
studi
tandem
reaction
isorhodanin
unsatur
carboxyl
acid
deriv
precis
number
stereochem
peculiar
process
establish
scheme
exampl
reaction
croton
acid
amid
anhydrid
mixtur
diastereom
form
isom
ratio
depend
natur
dienophil
reaction
temperatur
reaction
heterodien
maleic
fumar
acid
deriv
maleic
anhydrid
ester
pass
diastereoselect
moreov
independ
stereoisomer
dienophil
racem
mixtur
rel
thiopyrano
acid
deriv
cishydrogen
posit
heterocycl
system
form
itacon
acid
anhydrid
well
transaconit
acid
react
similar
manner
form
deriv
case
transaconit
acid
reaction
proceed
spontan
decarboxyl
posit
thiopyrano
thiazol
core
rel
thiopyrano
product
tandem
reaction
isorhodanin
cynnam
acid
compound
prove
effect
reagent
next
chemic
transform
reaction
primari
amin
acet
acid
pass
amid
stage
follow
spontan
recycl
spiroimid
thiopyrano
thiazol
also
obtain
altern
method
itacon
acid
imid
import
note
interact
isorhodanin
propiol
acid
classic
reaction
take
place
form
thiopyrano
thiazol
deriv
presenc
doubl
bond
posit
caus
planar
structur
bicycl
fragment
creat
spatial
obstacl
acyl
phenol
group
dehydrogen
basic
heterocycl
bromin
acet
acid
remov
obstacl
allow
obtain
tetracycl
thiopyrano
scheme
reaction
isorhodanin
furanon
proceed
diastereoselect
tandem
acylationheterodielsald
reaction
provid
novel
rel
thiopyrano
scheme
reaction
aryliden
pyruv
acid
yield
mixtur
rel
rel
diastereisom
ratio
time
acrolein
croton
cynnam
aldehyd
mention
tandem
heterodielsalderhemiacet
reaction
scheme
diastereoselect
yield
novel
rel
thiopyrano
addit
tandem
reaction
domino
reaction
also
play
import
role
synthesi
thiopyrano
thiazol
complex
structur
domino
reaction
involv
two
transform
result
format
bond
usual
bond
occur
reaction
condit
without
ad
new
reagent
andor
catalyst
process
subsequ
reaction
take
place
consequ
function
form
previou
step
one
exampl
thiopyranothiazol
scaffold
synthesi
obtain
seri
chromeno
thiopyrano
thi
one
isothiochromeno
domino
reaction
scheme
isorhodanin
citronel
note
reaction
isorhodanin
yield
mixtur
isom
author
propos
probabl
mechan
reaction
exoselect
cycliz
intermedi
heterodielsald
reaction
format
endointermedi
minor
process
recrystal
dioxan
provid
individu
tran
isom
tetracycl
deriv
synthes
altern
via
domino
thionationheterodielsald
reaction
nhacid
center
basic
core
compound
predetermin
transform
scheme
stage
potassium
salt
format
follow
alkyl
chloroacetamid
bromoacetophenon
ethyl
chloroacet
allow
obtain
new
nsubstitut
deriv
use
approach
scheme
isothiochromeno
alkyl
chloroacetamid
bromoacetophenon
give
deriv
treat
acrylonitril
cyanoethyl
reaction
result
propionitryl
format
anoth
exampl
domino
knoevenagelheterodielsald
reaction
scheme
interact
isorhodanin
structur
analog
benzaldehyd
well
e
reaction
allow
prepar
seri
pentacycl
deriv
character
tran
cisconfigur
proton
interestingli
e
use
reagent
stereoconfigur
final
product
similar
deriv
obtain
tandem
reaction
scheme
stereochemistri
final
compound
depend
endo
exoorient
dienophil
transit
state
presenc
allyl
moieti
molecul
induc
exotransit
state
contrast
cinnamoyl
fragment
caus
endoorient
dienophil
due
orbit
interact
intramolecular
knoevenagel
condens
scheme
ethyl
afford
intermedi
intramolecular
cycloaddit
provid
diastereoselect
format
ethyl
rel
thiopyrano
reaction
isorhodanin
benzaldehyd
medium
acet
acid
presenc
catalyt
amount
sodium
acet
stop
format
expect
thiopyrano
latter
underw
spontan
oxid
yield
thiopyrano
nsubstitut
isorhodanin
tradit
react
domino
reaction
provid
deriv
scheme
one
effici
freguent
use
direct
search
new
activ
compound
base
principl
privileg
structur
anneal
condens
system
approach
involv
combin
differ
heterocycl
pharmacophor
one
molecul
success
illustr
thiopyrano
thiazol
take
account
thiopyrano
thiazol
deriv
cyclic
isoster
mimet
without
typic
michael
acceptor
properti
studi
possibl
biolog
activ
compound
great
interest
thiopyrano
thiazol
studi
potenti
nonsterodi
antiinflammatori
drug
nsaid
exampl
antiinflammatori
activ
figur
acid
potassium
salt
identifi
carrageenaninduc
paw
edema
model
rat
compar
show
refer
drug
diclofenac
sodium
similar
activ
level
establish
rel
oxoacet
acid
like
mani
class
synthet
small
molecul
group
deriv
use
search
novel
select
antivir
agent
thiochromeno
possess
moder
activ
coronaviru
sar
si
abovement
deriv
also
show
micromolar
rang
cancer
cell
line
inhibit
low
toxic
level
activ
toward
line
leukemia
nonsmal
cell
lung
cancer
melanoma
one
class
thiopyranothiazol
deriv
test
antivir
activ
chromeno
thiopyrano
thiazol
show
inhibit
activ
influenza
viru
type
figur
posses
promis
influenc
ebv
viru
compound
si
hepat
c
viru
compound
si
respect
studi
antituberculosi
activ
thiopyranothiazol
allow
identifi
hitcompound
thiochromeno
promis
antimycobacteri
activ
mycobacterium
tuberculosi
strain
low
vivo
toxic
profil
gener
antimicrobi
antifung
antimycobacteri
profil
among
first
type
biolog
activ
describ
thiopyranothiazol
figur
particular
screen
structur
simpl
thiopyrano
thiazol
use
diskdiffus
method
moderatehigh
antimicrobi
antifung
activ
pseudomona
lachryman
erwinia
toxica
penicillium
simplex
ulocladium
chertorium
aspergillu
oryza
identifi
deriv
moreov
deriv
structur
inhibit
growth
mycobacterium
sp
studi
seri
condens
analog
result
identifi
potent
activ
compound
thiazol
shown
besid
antimicrobi
b
subtili
antitubercul
activ
high
antifung
potenti
figur
signific
influenc
staphylococcu
aureu
bacillu
subtili
candida
albican
identifi
rel
acid
one
popular
promis
direct
fuse
deriv
investig
search
anticanc
agent
howev
unlik
monocycl
mechan
antitumor
activ
well
understood
yet
moreov
quit
often
biophor
fragment
activ
deriv
save
pharmacolog
effect
new
polycycl
scaffold
latter
may
consid
argument
favour
given
class
compound
sourc
small
druglik
molecul
particular
anticanc
agent
thu
among
fuse
polycycl
thiazolothiopyran
larg
number
compound
character
high
inhibit
rate
andor
cytostat
activ
toward
cell
line
leukemia
nonsmal
cell
lung
cancer
renal
cancer
melanoma
ovarian
cancer
breast
cancer
prostat
cn
cancer
identifi
seri
nsubstitut
chromeno
thiopyrano
thiazol
reveal
suffici
high
level
growth
inhibit
differ
cancer
cell
avarag
valu
vitro
studi
figur
activ
compound
ntrifluoromethylphenyl
fragment
molecul
character
cytostat
effect
panel
cancer
cell
line
hand
substitu
posit
tetracycl
increas
select
activ
leukemia
cell
line
observ
submicromolar
concentr
ccrfcem
tb
whilst
inhibit
activ
cancer
cell
turn
rel
low
interestingli
structur
relat
fuse
system
isothiochromeno
thiazol
figur
substitu
posit
also
show
high
antitumor
effect
along
low
acut
cytotox
level
one
chemic
modif
direct
thiopyranothiazol
introduct
norbornan
fragment
molecul
figur
thu
thopyranothiazol
system
type
substitu
posit
main
core
inhibit
cancer
cell
growth
submicromolar
concentr
structur
relat
nsubstitut
heteryl
moder
activ
toward
panel
cancer
cell
line
show
rather
good
growth
inhibit
leukemia
cell
line
modif
main
thiopyranothiazol
scaffold
allow
synthesi
deriv
naphthoquinon
fragment
latter
show
high
level
anticanc
activ
moder
select
toward
melanoma
cell
worth
mention
benzo
thiochromeno
also
antituberculosi
activ
compound
figur
low
acut
toxic
high
anticanc
activ
identifi
row
heptadecen
activ
hitcompound
herewith
select
inhibit
growth
leukemia
cell
line
ccrfcem
log
sr
log
show
high
level
antimitot
activ
leukemia
mean
valu
one
promis
quit
new
direct
thiazolidinon
deriv
investig
search
potent
antiparasit
agent
name
compound
exhibit
antitrypanosom
activ
trypanosomiasi
belong
call
world
neglect
diseas
caus
trypanosoma
spp
among
spiro
thiopyrano
thiazol
deriv
activ
compound
inhibit
growth
trypanosoma
brucei
brucei
trypanosoma
brucei
gambiens
caus
agent
african
trypanosomiasi
valu
respect
identifi
interest
dual
antileukem
log
trypanocid
effect
observ
thiopyranothiazol
bear
norbornan
moieti
may
use
establish
molecular
mode
action
class
compound
figur
summaris
fuse
thiopyranothiazol
use
sourc
new
antibacteri
well
antivir
agent
also
inhibit
parasit
growth
result
correl
establish
anticanc
profil
thiopyranothiazol
moreov
fuse
heterocycl
investig
potent
nonsteroid
antiinflammatori
agent
structureact
relationship
outlin
figur
effici
approach
thiopyranothiazol
scaffold
synthesi
outlin
review
one
studi
synthet
protocol
thiopyranothiazol
cycloaddit
rather
fast
effici
method
yield
good
outcom
stereoselect
product
tandem
process
base
michael
reaction
use
thiopirano
thiazol
synthesi
also
discuss
contrast
well
discrib
variou
synthet
rout
thiopyranothiazol
synthesi
biolog
activ
deriv
studi
much
nevertheless
consid
synthet
biomimet
save
pharmacolog
profil
without
reveal
michael
acceptor
properti
among
establish
biolog
activ
thiopyrano
thiazol
deriv
antiinflammatori
antibacteri
anticanc
well
aniparasit
activ
promin
need
indepth
studi
consid
direct
search
new
druglik
molecul
possibl
chemotherapeut
agent
among
thiopyrano
thiazol
deriv
justifi
promis
direct
medicin
chemistri
moreov
way
anneal
thiazolidin
core
thiopyranothiazol
analog
use
one
molecular
optim
direct
decreas
toxic
andor
avoid
michael
acceptor
properti
well
